YC Companies/Winter 2020/Ansa Biotechnologies
Ansa Biotechnologies logo

Ansa Biotechnologies

Next-generation DNA synthesis using enzymes

Winter 2020Healthcare / Healthcare -> Industrial BioEmeryville, CA, USA72 employees
Synthetic Biology
Biotech

About

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.

Build your own investing agent

GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.

Join the GPAgent waitlist

Founders (2)

Dan Lin-Arlow
Founder
Sebastian Palluk
Founder

Details

Status
Active
Stage
Early
Team Size
72
Regions
United States of America, America / Canada, Remote, Partly Remote